Government of Canada / Gouvernement du Canada
Skip to left navigationSkip over navigation bars to content
Canada's Access to Medicines Regime

Map of the world

Forms

Copies of the forms required for the application package are provided in portable document format (PDF) and in Microsoft Word (DOC) format on this website. The Word files have fields for the required information and can be completed in electronic form. For the most up-to-date versions of the forms, consult the Next link will open in a new window Canadian Intellectual Property Office website for the Regime.

  • "Application for Authorization Under Section 21.04 of the Patent Act"
    (Patent Act (PDF version will open in a new window) 45 kB; Patent Act (Microsoft Word (DOC) version will open in a new window) 54 kB): Application for a compulsory licence to manufacture and export a generic version of a patented pharmaceutical product or medical device.
  • "Solemn or Statutory Declaration Under Paragraph 21.04(3)(c) of the Patent Act"
    (Patent Act (PDF version will open in a new window) 70 kB; Patent Act (Microsoft Word (DOC) version will open in a new window) 43 kB): Declaration that the applicant sought a voluntary licence from the patent holder or holders.
  • "Solemn or Statutory Declaration Under Paragraph 21.04(3)(d)(i)(A) of the Patent Act"
    (Patent Act (PDF version will open in a new window) 45 kB; Patent Act (Microsoft Word (DOC) version will open in a new window) 42 kB): Declaration regarding the identity and patent status of the pharmaceutical product or medical device (Schedule 2, WTO member, product not patented).
  • "Solemn or Statutory Declaration Under Paragraph 21.04(3)(d)(i)(B) of the Patent Act"
    (Patent Act (PDF version will open in a new window) 41 kB; Patent Act (Microsoft Word (DOC) version will open in a new window) 39 kB): Declaration regarding the identity and patent status of the pharmaceutical product or medical device (Schedule 2, WTO member, product is patented).
  • "Solemn or Statutory Declaration Under Paragraph 21.04(3)(d)(ii)(A) of the Patent Act"
    (Patent Act (PDF version will open in a new window) 45 kB; Patent Act (Microsoft Word (DOC) version will open in a new window) 42 kB): Declaration regarding the identity and patent status of the pharmaceutical product or medical device (Schedule 2, not WTO member, product not patented).
  • "Solemn or Statutory Declaration Under Paragraph 21.04(3)(d)(ii)(B) of the Patent Act"
    (Patent Act (PDF version will open in a new window) 41 kB; Patent Act (Microsoft Word (DOC) version will open in a new window) 40 kB): Declaration regarding the identity and patent status of the pharmaceutical product or medical device (Schedule 2, not WTO member, product is patented).
  • "Solemn or Statutory Declaration Under Paragraph 21.04(3)(d)(iii)(A), (iv)(A) or (v)(A) of the Patent Act"
    (Patent Act (PDF version will open in a new window) 41 kB; Patent Act (Microsoft Word (DOC) version will open in a new window) 41 kB): Declaration regarding the identity and patent status of the pharmaceutical product or medical device (Schedule  3 or 4, product not patented).
  • "Solemn or Statutory Declaration Under Paragraph 21.16(1)(b) of the Patent Act"
    (Patent Act (PDF version will open in a new window) 45 kB; Patent Act (Microsoft Word (DOC) version will open in a new window) 43 kB): Declaration regarding the monetary value of the pharmaceutical product or medical device and the number of units to be manufactured and sold.
  • "Application for Renewal of Authorization Under Section 21.12 of the Patent Act"
    (Patent Act (PDF version will open in a new window) 44 kB; Patent Act (Microsoft Word (DOC) version will open in a new window) 54 kB): Application for renewal of authorization for compulsory licence.
Last Updated: 2006-07-28 Top